Actual timepoints come directly from published trial data at specific weeks: 4, 8, 12, 16, 20, 24, 32, 40, and 48
Retatrutide is an investigational peptide drug developed by Eli Lilly that acts as a triple agonist, simultaneously targeting three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Figure 2 Macrophages serve as key regulators of inflammatory tone
What Colorado Springs Patients Say After Their Medical Weight Loss Journey The true measure of our success lies in the transformations our patients experience
Hirsutism and PCOS Spironolactone is used in the management of hirsutism (excessive hair growth) and polycystic ovary syndrome (PCOS) in women
However, the FDA says that when there is a shortage of a particular drug, compounding is allowed to ensure the patient can access treatment